The importance of sleep blood pressure

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 6, 2010, Pages 803-809

  Morgan, Trefor Owen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiac hypertrophy; Dippers; Myocardial infarction; Nondippers; Renin angiotensin system; Sleep blood pressure; Stroke; Sympathetic nervous system

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; INDAPAMIDE PLUS PERINDOPRIL; PERINDOPRIL; RAMIPRIL; TRANDOLOPRIL; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT;

ADRENERGIC SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DRUG EFFECT; HEART DISEASE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; NIGHT SLEEP; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; CHRONOTHERAPY; CIRCADIAN RHYTHM; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; HUMANS; HYPERTENSION; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; SLEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 77953512600     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.60     Document Type: Review

References (51)

1. Littler WA, Honour AJ, Carter RD, Sleight P. Sleep and blood pressure. Br. Med. J. 3(5979), 346-348 (1975).
2. Sega R, Corrao G, Bombelli M et al. Blood pressure variability and organ damage in a general population:results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 39, 710-714 (2002).
3. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 60, 1210-1215 (1985).
4. Brandenberger G, Follenius M, Goichot B, Saini J, Ehrhart J, Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep awake cycle. J. Hypertens. 12, 277-283 (1994).
5. Stergiou GS, Mastorantonakis SE, Roussias LG. Intraindividual reproducibility of blood pressure surge upon rising after nighttime sleep and siesta. Hypertens. Res. 10, 1859-1864 (2008).
6. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 2, 397 (1998).
7. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press. Monit. 6, 63-72 (2001).
8. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 81, 700-702 (1990).
9. Verdecchia P, Porcellati C, Schillaci G et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 24, 793-801 (1994).
10. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens. 10, 875-878 (1992).
11. Fujii T, Uzu T, Nishimura M et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am. J. Kidney Dis. 33, 29-35 (1999). (Pubitemid 29031205)
12. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 96, 1859-1862 (1997). (Pubitemid 27400745)
13. Fukuda M, Mizuno M, Yamanaka T et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 52, 1155-1160 (2008).
14. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355, 725-726 (2000).
15. Redon J, Plancha E, Swift PA, Pons S, Muñoz J, Martinez F. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J. Hypertens. 3, 602-607 (2010).
16. Boggia J, Li Y, Thijs L et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370, 1219-1229 (2007).
17. Dolan E, Stanton A, Thijs L et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46, 156-161 (2005).
18. Eguchi K, Hoshide S, Hoshide Y, Ishikawa S, Shimada K, Kario K. Reproducibility of ambulatory blood pressure in treated and untreated hypertensive patients. J. Hypertens. 28(5), 918-924 (2010).
19. Metoki H, Ohkubo T, Kikuya M et al. Prognostic significance of night-time, early morning, and daytime blood pressures on the risk of cerebrovascular and cardiovascular mortality: the Ohasama Study. J. Hypertens. 24(9), 1841-1848 (2006).
20. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81, 528-536 (1990).
21. Staessen JA, Thijs L, Fagard R et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 282, 539-546 (1999).
22. Wing L, Reid C, Ryan P, Beilin L, Brown M. High Blood Pressure Research Council of Australia Outcome related to clinic and ambulatory blood pressure in the Second Australian National Blood Pressure Study (ANBP2). J. Hypertens. 22(Suppl. 1), S58 (2004).
23. Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA. Outcome related to on-treatment clinic and ambulatory blood pressure in the Second Australian National Blood Pressure Study (ANBP2). Clin. Exp. Pharmacol. Physiol. 32(7), A7 (2005).
24. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J. Hypertens. 26, 1636-1641 (2008).
25. Kanemaru A, Kanemaru K, Kuwajima I. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens. Res. 24, 19-24 (2001).
26. Astrup AS, Nielsen FS, Rossing P et al. Predictors of mortality in patients with Type 2 diabetes with or without diabetic nephropathy: a follow-up study. J. Hypertens. 25(12), 2479-2485 (2007).
27. Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin. Exp. Hypertens. 26, 177-189 (2004).
28. Gosse P, Lasserre R, Minifié C, Lemetayer P, Clement J. Blood pressure surge on rising. J. Hypertens. 22(6), 1113-1118 (2004).
29. Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: prospective study. Circulation 107, 1401-1406 (2003).
30. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79, 733-743 (1989).
31. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J. Hypertens. 9, 1335-1343 (1998).
32. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am. J. Cardiol. 70, 65-68 (1992).
33. Morgan T, Brunner H, Aubert J-F, Connell P. The relationship of blood pressure to cardiac hypertrophy: experimental studies in rats. Clin. Exp. Hypertens. 19, 827-841 (1997).
34. Morgan TO, Brunner HR, Aubert J-F, Wang Q, Griffiths C, Delbridge L. Cardiac hypertrophy depends upon sleep blood pressure: a study in rats. J. Hypertens. 18, 445-451 (2000).
35. Lurbe E, Redon J, Kesani A et al . Increase in nocturnal blood pressure and progression to microalbuminuria in Type 1 diabetes. N. Engl. J. Med. 347, 797-805 (2002).
36. Nakano S, Fukuda M, Hotta F et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 47, 1501-1506 (1998).
37. Esler M. Depressive illness, the sympathetic nervous system and cardiac risk. J. Hypertens. 27(12), 2349-2350 (2009).
38. Kario K, Schwartz JE, Pickering TG. Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 34, 685-691 (1999).
39. Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 19, 2271-2277 (2001).
40. Kario K, Schwartz JE, Davidson KW, Pickering TG. Gender differences in associations of diurnal blood pressure variation, awake physical activity, and sleep quality with negative affect: the work site blood pressure study. Hypertension 38(5), 997-1002 (2001).
41. Watanabe T, Matsuura T, Watanabe M, Dote T, Simizu H, Kono K. The relationship between ambulatory blood pressure variation and symptoms of depression and sleep disturbance in community-dwelling elderly persons with independent activities of daily living. Nippon Koshu Eisei Zasshi 49, 178-187 (2002).
42. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am. J. Hypertens. 16, 46-50 (2003).
43. Lacourcière Y, Lenis J, Orchard R et al. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine. Blood Press. Monit. 3, 295-302 (1998).
44. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J. Hypertens. 15, 205-211 (1997).
45. Smith DHG, Neutel JM, Black HR, Schoenberger JA, Weber MA. Once daily therapy with trandolapril in the treatment of hypertension. J. Hum. Hypertens. 10, 129-134 (1996).
46. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of a-adrenergic blocker, doxazosin : results from the HALT study. Hypertension 35, 787-794 (2000).
47. Hermida R, Ayala D. Chronotherapy with ramipril in essential hypertension: improved ambulatory blood pressure control with bedtime dosing. Hypertension 54, 40-46 (2009).
48. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 145-153 (2000). (Pubitemid 30051645)
49. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 38, E28-E32 (2001).
50. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358, 1033-1041 (2001).
51. Fox KM; European Trial On Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease; randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362, 782-788 (2003).